US 2022/0033366 A1Published application

Compounds useful for treatment or prevention of muscular dystrophy and derivatives for treatment, amelioration or prevention of muscular dystrophy in medicinal use thereof

AssigneeJ2H Biotech Inc.

InventorsHyung-Chul RYU, Jae-Sun KIM, Jee-Woong LIM, Ju-Young LEE, Wenling SONG, Tae-Gon KIM

Life of this patent

Estimating the term…

Abstract

The present invention relates to a novel compound and a medicinal use of the novel compound. In particular, the present invention relates to a novel compound useful for the treatment and/or prevention of muscular dystrophy, including Duchenne muscular atrophy, and a medicinal use of the novel compound.

Claims9

Dependent claims

A compound represented by the following Chemical formula 1.

In Chemical Formula 1,
L is selected from the group consisting of straight or branched alkyl having 1 to 3 carbon atoms and benzyl.

Dependencies are inferred from the claim text.

Facts

Application: 17/413,608Filed 24 Dec 2019
Priority: KR 10-2018-017096527 Dec 2018
Published: 3 Feb 2022
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

C07D 271/06
Not condensed with other rings: 1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
A61K 31/4245
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: oxadiazoles
A61P 21/00
Drugs for disorders of the muscular or neuromuscular system
C07D
Heterocyclic compounds

Family

US 11,485,716 B2Related patent
US 2022/0033366 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results